Skip to Content

PLAQUENIL (Plaquenil sulfate 200 mg)

Pill imprint PLAQUENIL has been identified as Plaquenil sulfate 200 mg.

Hydroxychloroquine is used in the treatment of systemic lupus erythematosus; rheumatoid arthritis; undifferentiated connective tissue disease; sjogren's syndrome; lyme disease, arthritis (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy. Hydroxychloroquine 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Plaquenil sulfate 200 mg PLAQUENIL
Plaquenil sulfate 200 mg PLAQUENIL
Plaquenil sulfate 200 mg PLAQUENIL  Front
Plaquenil sulfate 200 mg PLAQUENIL  Back
Plaquenil sulfate 200 mg PLAQUENIL
Plaquenil sulfate
Imprint:
PLAQUENIL
Strength:
200 mg
Color:
White
Size:
12.00 mm
Shape:
Figure eight-shape
Availability:
Prescription only
Drug Class:
Antimalarial quinolines
Antirheumatics
Pregnancy Category:
N - Not classified
CSA Schedule:
Not a controlled drug
Manufacturer:
Sanofi-Aventis
National Drug Code (NDC):
00024-1562
Inactive Ingredients:
calcium phosphate dibasic anhydrous
hypromelloses
magnesium stearate
polyethylene glycol 400
polysorbate 80
corn starch
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
66993-0057 Prasco Laboratories
42291-0335 AvKare, Inc.

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide